News|Articles|November 10, 2023

The Path Forward: Navigating the DSCSA Stabilization Policy

Name: The Path Forward: Navigating the DSCSA Stabilization Policy
Uploaded: 2023-11-10T19:07:06.195Z
Duration: 30 minutes
Description: Elizabeth Gallenagh, JD, general counsel and senior vice president of supply chain integrity at the Healthcare Distribution Alliance

Learn more about the ins and outs of the new DSCSA stabilization policy, delaying some facets of DSCSA implementation to November 2024.

Elizabeth Gallenagh, JD, general counsel and senior vice president of supply chain integrity at the Healthcare Distribution Alliance, Tish Pahl, JD, principal at Olsson Frank Weeda Terman Matz PC, and Scott Mooney, vice president of distribution operations at McKesson, discussed the FDA’s Drug Supply Chain Security Act (DSCSA) stabilization policy, which delays some facets of DSCSA implementation to November 2024.

Fall 2023: Leveraging Technology to Increase your Pharmacy's Revenue

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

$Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists$

Patient First: Delivering Value with Clinical & Preventive Services

The Path Forward: Navigating the DSCSA Stabilization Policy

Related Content

The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability

Why Advocacy Is Essential for Independent Pharmacy Survival

Pharmacy Leaders Set Priorities for Global Primary Care Integration

Digital Experience Crucial for Pharmacies to Drive Patient Retention

Q&A: Pharmacy Advocacy Strong Across Communities, Corporations

Latest CME

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Trending on Drug Topics

Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand

Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D

Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide

Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition

Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%